Scratching behavior induced by pruritogenic but not algesiogenic agents in mice

European Journal of Pharmacology
Y KuraishiM Satoh

Abstract

We compared the behavioral effects of treatment with pruritogenic and algesiogenic agents in mice. The animals were given subcutaneous injections of pruritogenic agents, compound 48/80 (3-100 micrograms), substance P (10-300 micrograms) and histamine (3-300 micrograms), and algesiogenic agents, capsaicin (30 and 100 micrograms) and dilute formalin (5 mg of formaldehyde), into the rostral back, and scratching of the injected site by the hind paws was counted. Compound 48/80 and substance P dose dependently elicited the scratching behavior, but histamine, capsaicin and dilute formalin were without significant effects at the doses examined. These results suggest that compound 48/80- and substance P-induced scratching of the injected site is due to itch, but not to pain. The data did not provide support for the idea that histamine produces itch in the mouse.

References

Sep 1, 1975·The British Journal of Dermatology·R Felix, S Shuster
Dec 1, 1992·Trends in Neurosciences·S B McMahon, M Koltzenburg
Jan 1, 1992·Skin Pharmacology : the Official Journal of the Skin Pharmacology Society·O Hägermark
Jan 1, 1992·Journal of the American Academy of Dermatology·D L BrenemanV E Pollack
Mar 5, 1991·European Journal of Pharmacology·H H Berendsen, C L Broekkamp
Apr 1, 1990·The British Journal of Dermatology·C F WahlgrenR Bergström
Sep 13, 1988·European Journal of Pharmacology·T B Van Wimersma Greidanus, C Maigret
Jun 1, 1985·Journal of Neuroscience Methods·S HunskaarK Hole
Aug 11, 1973·Lancet·J A SavinI Oswald
Oct 22, 1983·British Medical Journal·L Krause, S Shuster
Sep 1, 1980·The British Journal of Dermatology·J A Summerfield, M E Welch
May 28, 1953·The Journal of Physiology·D ARMSTRONGJ W MARKHAM
Jan 1, 1953·Acta Neurovegetativa·F HOBBIGER

❮ Previous
Next ❯

Citations

May 16, 2000·Journal of Biomedical Science·Y KuraishiT Miyamoto
Jan 1, 2000·Archives of Pharmacal Research·D H KimW B Kim
Jul 27, 2006·Archives of Dermatological Research·Frank LiebelMichael D Southall
Jun 16, 2010·Archives of Dermatological Research·Yasutomo FujiiShoji Takakura
Jan 1, 1996·Brain Research. Molecular Brain Research·T AndohY Kuraishi
Nov 26, 2003·European Journal of Pharmacology·Kenji HirayamaChiharu Kubo
Jul 29, 2000·European Journal of Pharmacology·N InagakiH Nagai
Sep 30, 2000·European Journal of Pharmacology·T Andoh, Y Kuraishi
Feb 1, 2002·European Journal of Pharmacology·Yuko TogashiHiroshi Nagase
Feb 23, 2002·European Journal of Pharmacology·Tsugunobu Andoh, Yasushi Kuraishi
Jul 30, 2002·European Journal of Pharmacology·Naoki InagakiHiroichi Nagai
Aug 28, 1998·European Journal of Pharmacology·T Andoh, Y Kuraishi
Oct 18, 2002·Life Sciences·Diane L DeHaven-HudkinsVirendra Kumar
Dec 14, 2002·Pharmacology, Biochemistry, and Behavior·Shinobu SakuradaTsukasa Sakurada
Feb 28, 2003·Lancet·Gil YosipovitchMartin Schmelz
Jun 20, 2003·Journal of Neuroscience Methods·Hiroshi Nojima, E Carstens
Oct 22, 2002·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·F A Santos, V S N Rao
Jun 18, 2002·Journal of Ethnopharmacology·Y DaiP P H But
Jan 13, 2001·Journal of Dermatological Science·T YamaguchiY Kuraishi
Jun 8, 2001·Journal of Pharmacological and Toxicological Methods·G R ElliottP L Bruijnzeel
May 11, 2010·Acta Pharmacologica Sinica·Hien-trung TrinhDong-hyun Kim
Mar 5, 2009·Nature Reviews. Neuroscience·Jeffrey S Mogil
Jan 11, 2003·British Journal of Pharmacology·Tsugunobu Andoh, Yasushi Kuraishi
Sep 11, 2003·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Masatomo KatoSuguru Miyaji
Mar 27, 2004·The Journal of Pharmacology and Experimental Therapeutics·M C H KoN N Naughton
Aug 8, 2009·Science·Yan-Gang SunZhou-Feng Chen
May 21, 2010·Journal of Neurophysiology·Junichi HachisukaMegumu Yoshimura
Sep 17, 2002·Biological & Pharmaceutical Bulletin·Yue DaiMichinori Kubo
Feb 21, 2002·Biological & Pharmaceutical Bulletin·Hideaki MatsudaMichinori Kubo
Jul 5, 2003·Biological & Pharmaceutical Bulletin·Hisae OkuKyoko Ishiguro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.